Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVICEL for reduction of blood loss in total knee replacement
DRKS00007564Phase 4Withdrawn
- Sponsor
- Medizinische Hochschule Hannover
- Start
- Nov 2014
- Modality
- Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of porcine fibrin sealant in primary osteoarthritis of knee and posthemorrhagic anemia (2 arms), sponsored by Medizinische Hochschule Hannover. Primary endpoint: Blood loss during and after surgery. Planned start Nov 2014; status: withdrawn.
02
Drugs
porcine fibrin sealant
03
Conditions
primary osteoarthritis of kneeposthemorrhagic anemia
Beyond the preview
Go deeper on DRKS00007564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00007564.